Atlas Trials

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Clinical trial NCT01196208 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT01196208
Sponsor
Seagen Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-HodgkinLymphoma, T-Cell, Cutaneous

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.